Since bottoming out at $1.92 in March 2020, shares of Lithium Americas (LAC) rocketed to a recent high of $5.78. All because there’s a potential lithium supply shortage. According to Reuters, “A new demand surge is already looming in the form of the multiple ‘green stimulus’ packages as governments try and kick-start locked-down economies. You don’t […]
Author: Ian Cooper
PFE Stock Price Jumps on Announcement of $1.95 Billion Payout From U.S. For COVID-19 Vaccine
Pfizer (PFE) just announced the U.S. government will pay $1.95 billion for PFE to produce and deliver 100 million doses of its COVID vaccine once the U.S. declares it’s safe and effective. Under the agreement, the U.S. can acquire an additional 500 million doses from PFE. “Through Operation Warp Speed, we are assembling a portfolio of vaccines […]
FATE Stock Price Jumps on License Agreement with Baylor College for Rejection-Resistant Cellular Therapies
Since bottoming out in March 2020, Fate Therapeutics (FATE) has run from a low of $19.91 to a current price of $35.50 with plenty of catalysts. For one, FATE just entered into an exclusive license agreement with Baylor College of Medicine covering alloimmune defense receptors, a first-in-class approach that renders off-the-shelf allogeneic cell products resistant […]
MRNA Stock Price Nears 52-Week Highs On COVID-19 Vaccine Results
All after the company said its potential COVID-19 vaccine produced a “robust” immune response in all 45 patients in an early stage human trial. “These Phase 1 data demonstrate that vaccination with mRNA-1273 elicits a robust immune response across all dose levels and clearly support the choice of 100 µg in a prime and boost […]
FATE Stock Price Expected to Jump On Clearance of FDA IND Application
Fate Therapeutics (FATE) has seen an incredible amount of momentum. Since March, the stock rocketed from a low of $19.92 to $38, as it moves progresses with cellular immunotherapies for cancer and immune disorders. FATE could see even further momentum on news the U.S. FDA cleared the company’s Investigational New Drug (IND) application for FT819, […]
NVAX Stock Price Jumps After Receiving $1.6 Billion Award from Federal Government
Over the last few days, shares of Novavax (NVAX) exploded from $79.80 to $111.77. All after the U.S. government awarded the NVAX a $1.6 billion contract to cover the testing, commercialization, and manufacturing of a potential vaccine — the biggest award issued from the White House’s “Operation Warp Speed” program. “What this Warp Speed award […]
ZNGA Stock Price at Year to Date High on News of Closing Deal with Peak
Since bottoming out in March 2020 at $5.65, ZNGA is now up to $9.77 as of this writing – and pushing higher. In recent days, the company and Peak, the creator of Toon Blast and Toy Blast, just closed the transaction under which ZNGA acquired all of the issued and outstanding common shares of Peak […]
APT Stock Price gains 70% in Recent Weeks on Uptick In New Coronavirus Cases Reported
With the coronavirus still wreaking havoc, shares of Alpha Pro Tech (APT) ran from a low of $10 to $17.70 in recent weeks. All as the coronavirus forces the world to demand more face masks. APT has been the “go-to” stock for investors looking for profits in the personal protection equipment (PPE) space outside of […]
NIO Stock Price Holds Around $7.00 With Investors Positive Following Liquidity Injection
NIO Inc. (NIO) just announced that the investors completed the cash injection obligations for the first two installments of their investments in NIO China. NIO (Anhui) Holding Co., Ltd., received from the investors RMB4.8 billion out of the RMB5 billion of cash investments for the first two installments. The remaining RMB200 million of the first […]
APT Doubles While Other Biotechs Take Off On Rising New Coronavirus Case Numbers
Over the last few weeks, shares of Alpha Pro Tech (APT) have exploded from a low of $9.05 to a recent high of $18.03. All as the number of coronavirus cases soar around the world – again. “The pandemic is still accelerating,” WHO’s director general Tedros Adhanom Ghebreyesus said. “We know that the pandemic is […]